Genitourinary Radiology: Page 68

CEUS aids in discriminating hypoechoic prostate lesions
By Erik L. Ridley
Contrast-enhanced grayscale transrectal ultrasound (CETRUS) may offer value in characterizing peripheral zone hypoechoic prostate lesions, according to research presented at the recent 2007 RSNA meeting in Chicago. Contrast-enhanced ultrasound offers an innovative approach for imaging neovascularity associated with prostate cancer, the team from China reported.
December 5, 2007
Confirma launches prostate MRI CAD, breast MRI upgrades at RSNA
By AuntMinnie.com staff writers
Computer-aided detection (CAD) developer Confirma of Bellevue, WA, unveiled its latest product, CADstream for prostate MRI, at this week's RSNA 2007 meeting in Chicago.
November 27, 2007
Gold marker implants for prostate radiotherapy safe, study finds
By Kate Madden Yee
Transrectal gold marker implantation for prostate position verification in radiotherapy is safe and well-tolerated, according to Dutch researchers. They analyzed the complication rates and identified the risk factors for complications in more than 200 prostate cancer patients who had received gold markers transrectally with ultrasound guidance.
November 19, 2007
Toshiba launches contrast-free MRI technique
By AuntMinnie.com staff writers
Toshiba America Medical Systems of Tustin, CA, has introduced a fourth-generation contrast-free imaging technique for MRI scanning, the company reported.
November 14, 2007
IsoRay posts Q1 2008 results
By AuntMinnie.com staff writers
Medical isotope developer IsoRay has posted financial results for its first quarter of 2008.
November 8, 2007
ASTRO: Younger men benefit from prostate brachytherapy
By Shalmali Pal
LOS ANGELES - Age should not be a deterrent for using brachytherapy as a primary treatment mode for young men with prostate cancer, according to a study presented this week at the American Society for Therapeutic Radiology and Oncology (ASTRO). In this analysis, men ages 60 and younger achieved "excellent" five-year biochemical control rates compared to their older counterparts (61 years and older).
October 31, 2007
Confirma
By Brian Casey
(Booth 7950) Confirma has focused on breast MRI CAD, and at this year's RSNA show the Bellevue, WA, company will demonstrate new reporting tools and a new user interface built around the American College of Radiology's BI-RADS lexicon. The company will also discuss its entry into prostate CAD.
October 31, 2007
E-Z-EM
By Cheryl Hall Harris, R.N.
(Booth 4720) Taking center stage in the E-Z-EM booth at this year's RSNA show will be EZ Chem, a handheld blood analyzer designed to help clinicians assess renal function and prevent contrast reactions by measuring creatinine levels.
October 21, 2007
2007 10 18 16 05 43 706
Abaxis debuts Kidney Check Panel
By AuntMinnie.com staff writers
Portable blood analysis systems developer Abaxis has introduced Kidney Check Panel for use with its Piccolo xpress point-of-care analyzer.
October 3, 2007
Confirma completes four installations
By AuntMinnie.com staff writers
Computer-aided detection (CAD) developer Confirma of Bellevue, WA, has installed its CADstream for prostate software at four research sites, including Beth Israel Hospital in Boston and the Lahey Clinic in Burlington, MA.
October 1, 2007
Contrast vendors send gadolinium NSF letter
By AuntMinnie.com staff writers
The major manufacturers of gadolinium-based MRI contrast agents have sent a letter to healthcare professionals alerting them to the possible relationship between the agents and nephrogenic systemic fibrosis (NSF).
September 30, 2007
Combining T2-weighted MRI and DWI improves prostate cancer detection
By Radiology Review
(Radiology Review) Combined T2-weighted MRI and diffusion-weighted imaging (DWI) is significantly better than T2-weighted imaging alone for detecting peripheral zone prostate cancer, according to a report in the August issue of American Journal of Roentgenology.
September 20, 2007
Previous Page
Page 68 of 93
Next Page